Processa Pharmaceuticals (PCSA) Preferred Shares (2012 - 2017)
Processa Pharmaceuticals' (PCSA) quarterly Preferred Shares came in at $18.0 in Q2 2017, little changed YoY from $18.0 in Q2 2016, and little changed on a QoQ basis from $18.0 in Q1 2017.
Processa Pharmaceuticals (PCSA) Preferred Shares (2012 - 2017) Analysis & Trends
Processa Pharmaceuticals (PCSA) has 6 years of Preferred Shares data on file, last reported at $18.0 in Q2 2017.
- Quarterly Preferred Shares changed 0.0% year-over-year to $18.0 in Q2 2017, while the trailing twelve-month figure through Jun 2017 was $18.0 (changed 0.0% YoY) and the FY2016 annual result came in at $18.0, changed 0.0% from the prior year.
- Preferred Shares was little changed at $18.0 in Q2 2017, from $18.0 in the prior quarter.
- In the past five years, Preferred Shares ranged from a high of $107.0 in Q2 2013 to a low of $18.0 in Q4 2014.
- A 5-year average of $45.88 and a median of $18.0 in 2014 frame the typical range for Preferred Shares.
- Annual changes were most pronounced in 2014 — Preferred Shares sank 82.18% — and 2015, when it changed 0.0%.
- Tracing PCSA's Preferred Shares over 5 years: stood at $101.0 in 2013, then slumped by 82.18% to $18.0 in 2014, then changed by 0.0% to $18.0 in 2015, then changed by 0.0% to $18.0 in 2016, then changed by 0.0% to $18.0 in 2017.
- The last three Preferred Shares figures came in at $18.0 (Q2 2017), $18.0 (Q1 2017), and $18.0 (Q4 2016), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | - |
| 10 | Processa Pharmaceuticals | 5.78 Mn | 5.78 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 18.00 |
| Mar 31, 2017 | 18.00 |
| Dec 31, 2016 | 18.00 |
| Sep 30, 2016 | 18.00 |
| Jun 30, 2016 | 18.00 |
| Mar 31, 2016 | 18.00 |
| Dec 31, 2015 | 18.00 |
| Sep 30, 2015 | 18.00 |
| Jun 30, 2015 | 18.00 |
| Mar 31, 2015 | 18.00 |
| Dec 31, 2014 | 18.00 |
| Sep 30, 2014 | 88.00 |
| Jun 30, 2014 | 89.00 |
| Mar 31, 2014 | 93.00 |
| Dec 31, 2013 | 101.00 |
| Sep 30, 2013 | 104.00 |
| Jun 30, 2013 | 107.00 |
| Dec 31, 2012 | 286.00 |